Accelerating cancer research through comprehensive genomic analysis


In this white paper, you will learn how cancer researchers are using nanopore sequencing to overcome the key challenges associated with short-read sequencing technologies to deliver:

  • More compete and contiguous cancer genome assemblies
  • Accurate resolution of structural variants and repeat regions
  • Rapid identification of fusion genes and full-length transcript isoforms
  • Detection of low-abundance cell-free DNA (cfDNA) and circulating tumour DNA (ctDNA)
  • Streamlined sequencing of targeted regions and panels
  • Epigenetic base modification detection as standard — no additional sample prep or sequencing runs required

Read customer case studies describing the detection of a wide variety of genomic variants across a wide range of cancers, including cervical cancer, colorectal cancer, acute myeloid leukaemia, and tumeroids.